- Home
- SIG vs CERT Comparison
SIG vs CERT Comparison
Compare SIG & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIG
- CERT
- Stock Information
- Founded
- SIG 1950
- CERT 2008
- Country
- SIG Bermuda
- CERT United States
- Employees
- SIG N/A
- CERT N/A
- Industry
- SIG Consumer Specialties
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- SIG Consumer Discretionary
- CERT Technology
- Exchange
- SIG Nasdaq
- CERT Nasdaq
- Market Cap
- SIG 2.3B
- CERT 2.3B
- IPO Year
- SIG N/A
- CERT 2020
- Fundamental
- Price
- SIG $58.85
- CERT $9.91
- Analyst Decision
- SIG Buy
- CERT Buy
- Analyst Count
- SIG 4
- CERT 6
- Target Price
- SIG $74.00
- CERT $15.80
- AVG Volume (30 Days)
- SIG 1.8M
- CERT 1.3M
- Earning Date
- SIG 03-19-2025
- CERT 05-06-2025
- Dividend Yield
- SIG 2.18%
- CERT N/A
- EPS Growth
- SIG N/A
- CERT N/A
- EPS
- SIG N/A
- CERT N/A
- Revenue
- SIG $6,703,800,000.00
- CERT $385,148,000.00
- Revenue This Year
- SIG $2.08
- CERT $11.44
- Revenue Next Year
- SIG $1.23
- CERT $8.90
- P/E Ratio
- SIG N/A
- CERT N/A
- Revenue Growth
- SIG N/A
- CERT 8.70
- 52 Week Low
- SIG $45.55
- CERT $9.41
- 52 Week High
- SIG $112.06
- CERT $19.18
- Technical
- Relative Strength Index (RSI)
- SIG 59.22
- CERT 26.70
- Support Level
- SIG $59.10
- CERT $10.21
- Resistance Level
- SIG $61.80
- CERT $11.12
- Average True Range (ATR)
- SIG 2.39
- CERT 0.49
- MACD
- SIG 1.48
- CERT -0.05
- Stochastic Oscillator
- SIG 81.85
- CERT 14.20
About SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-mall & Outlet.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.